Abstract
A double-blind, five phase, cross-over clinical trial was used to compare a mucin-based artificial saliva (Saliva Orthana) with its non-mucin base and water. Thirty patients, acting as their own controls, took part. Saliva Orthana offered significantly greater relief from xerostomia compared with its base or water, and was significantly better at relieving soreness than water. In terms of overall preference, it was ranked significantly higher than either alternative
Article PDF
Rights and permissions
About this article
Cite this article
Duxbury, A., Thakker, N. & Wastell, D. A double-blind cross-over trial of a mucin-containing artificial saliva. Br Dent J 166, 115–120 (1989). https://doi.org/10.1038/sj.bdj.4806731
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bdj.4806731
This article is cited by
-
World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment
Clinical Oral Investigations (2015)
-
A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact
Supportive Care in Cancer (2010)
-
Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia
Supportive Care in Cancer (2007)